Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas Thornton

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
Journal of Substance Abuse Treatment|August 20, 2020
Chronic prescription opioid use predicts stabilization on buprenorphine for the treatment of opioid use disorderTyler Varisco, Chan Shen, Douglas Thornton
SAGE Open Medicine|March 29, 2017
Use of selective-serotonin reuptake inhibitors and platelet aggregation inhibitors among individuals with co-occurring atherosclerotic cardiovascular disease and depression or anxietyJ Douglas Thornton, Parul Agarwal, Usha Sambamoorthi
Journal of Pain Research|July 15, 2025
Association Between Opioid Use and Emergency Department Visits for Spine-Related DisordersChijioke Okeke, Godwin Okoye, J Douglas Thornton
Journal of Substance Use and Addiction Treatment|October 21, 2025
Gaps in buprenorphine access: Examining provider availability and treatment continuityAbolfazl Sadeghi, J Douglas Thornton, Tyler J Varisco
Health Affairs Scholar|May 30, 2024
The Affordable Care Act and income-based disparities in health care coverage and spending among nonelderly adults with cancerOlajumoke A Olateju, Chan Shen, James Douglas Thornton
Journal of Substance Use and Addiction Treatment|June 12, 2025
Association between buprenorphine adherence for opioid use disorder and clinical events and healthcare spending among older patientsOlajumoke A Olateju, Mina Shrestha, J Douglas Thornton
Journal of Managed Care & Specialty Pharmacy|August 30, 2025
Capivasertib cost-effectiveness in treating advanced breast cancer: A US health care perspectiveChijioke Okeke, Javeria Khalid, J Douglas Thornton, et al.
Drug and Alcohol Review|September 11, 2025
Buprenorphine Adherence Trajectories and Their Impact on Opioid Overdose and Healthcare CostsOlajumoke A Olateju, Tyler Varisco, Scott Weiner, et al.
Currents in Pharmacy Teaching & Learning|October 29, 2025
Textbook reading habits and perceptions among PharmD students in an integrated curriculum: A mixed-methods analysisJoydip Das, Rudi Safarudin, J Douglas Thornton, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|March 30, 2017
Direct and indirect cost of managing alzheimer's disease and related dementias in the United StatesArijita Deb, James Douglas Thornton, Usha Sambamoorthi, et al.
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Journal of Substance Abuse Treatment|August 20, 2020
Chronic prescription opioid use predicts stabilization on buprenorphine for the treatment of opioid use disorderTyler Varisco, Chan Shen, Douglas Thornton
SAGE Open Medicine|March 29, 2017
Use of selective-serotonin reuptake inhibitors and platelet aggregation inhibitors among individuals with co-occurring atherosclerotic cardiovascular disease and depression or anxietyJ Douglas Thornton, Parul Agarwal, Usha Sambamoorthi
Journal of Pain Research|July 15, 2025
Association Between Opioid Use and Emergency Department Visits for Spine-Related DisordersChijioke Okeke, Godwin Okoye, J Douglas Thornton
Journal of Substance Use and Addiction Treatment|October 21, 2025
Gaps in buprenorphine access: Examining provider availability and treatment continuityAbolfazl Sadeghi, J Douglas Thornton, Tyler J Varisco
Health Affairs Scholar|May 30, 2024
The Affordable Care Act and income-based disparities in health care coverage and spending among nonelderly adults with cancerOlajumoke A Olateju, Chan Shen, James Douglas Thornton
Journal of Substance Use and Addiction Treatment|June 12, 2025
Association between buprenorphine adherence for opioid use disorder and clinical events and healthcare spending among older patientsOlajumoke A Olateju, Mina Shrestha, J Douglas Thornton
Journal of Managed Care & Specialty Pharmacy|August 30, 2025
Capivasertib cost-effectiveness in treating advanced breast cancer: A US health care perspectiveChijioke Okeke, Javeria Khalid, J Douglas Thornton, et al.
Drug and Alcohol Review|September 11, 2025
Buprenorphine Adherence Trajectories and Their Impact on Opioid Overdose and Healthcare CostsOlajumoke A Olateju, Tyler Varisco, Scott Weiner, et al.
Currents in Pharmacy Teaching & Learning|October 29, 2025
Textbook reading habits and perceptions among PharmD students in an integrated curriculum: A mixed-methods analysisJoydip Das, Rudi Safarudin, J Douglas Thornton, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|March 30, 2017
Direct and indirect cost of managing alzheimer's disease and related dementias in the United StatesArijita Deb, James Douglas Thornton, Usha Sambamoorthi, et al.
Pageof 9